← Leaderboards
Larisa Humma Cavallari
University Of Illinois At Chicago
$8,271,762
Attributed
$13,899,601
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2008–24$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,384,419 · 3
FDA$2,515,182 · 1
By mechanism
U01$10,232,900 · 2
R01$3,537,961 · 1
R03$128,740 · 1
Top collaborators
- Julie A. Johnson7 shared
- Craig R Lee5 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Dawood Darbar$15,920,976
Others in their field
Top investigators on “Genotype”
- David R. Weir · University Of Michigan At Ann Arbor$303,033,420
- Richard A Gibbs · Baylor College Of Medicine$211,329,145
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Stacey Gabriel · Massachusetts Institute Of Technology$153,486,482
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$141,132,078
Research focus
GenotypeAcutePopulation HeterogeneityCostResponseHigh RiskGenetic TestingParticipantLoss Of FunctionCytochrome P450Clinical PracticeSafetyEnzymesMetabolismEffectivenessClinically RelevantGenetic VariantAfrican American PopulationPersonsGenomic MedicineInvestigationFloridaGeneticBase
Grant awards (18)
Precision antiplatelet therapy after percutaneous coronary intervention$665,268
R01 · FY2024 · HL · contact PI
IGNITE EP2 - Admin Supplement$258,184
U01 · FY2024 · HG · contact PI
IGNITE Cost Extension - Admin Supplement$1,351,790
U01 · FY2023 · HG · contact PI
Precision antiplatelet therapy after percutaneous coronary intervention$682,731
R01 · FY2023 · HL · contact PI
Sparking Advancements in Genomic Medicine$1,290,318
U01 · FY2022 · HG · contact PI
Sparking Advancements in Genomic Medicine$750,442
U01 · FY2022 · HG · contact PI
Precision antiplatelet therapy after percutaneous coronary intervention$721,954
R01 · FY2022 · HL · contact PI
Sparking Advancements in Genomic Medicine$623,311
U01 · FY2022 · HG
Sparking Advancements in Genomic Medicine$925,611
U01 · FY2021 · HG
Precision antiplatelet therapy after percutaneous coronary intervention$718,145
R01 · FY2021 · HL · contact PI
Sparking Advancements in Genomic Medicine$2,518,062
U01 · FY2020 · HG
Precision antiplatelet therapy after percutaneous coronary intervention$749,863
R01 · FY2020 · HL · contact PI
Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01)$182,312
U01 · FY2017 · FD · contact PI
Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01)$729,254
U01 · FY2016 · FD · contact PI
Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01)$981,267
U01 · FY2015 · FD · contact PI
Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01)$622,349
U01 · FY2014 · FD · contact PI
Genetic determinants of aldosterone escape in heart failure$64,370
R03 · FY2009 · AG · contact PI
Genetic determinants of aldosterone escape in heart failure$64,370
R03 · FY2008 · AG · contact PI